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Background-—Experimental studies characterize adaptive immune response as a critical factor in the progression and
complications of atherosclerosis. Yet, it is unclear whether these observations translate to the human situation. This study
systematically evaluates cellular components of the adaptive immune response in a biobank of human aortas covering the full
spectrum of atherosclerotic disease.
Methods and Results-—A systematic analysis was performed on 114 well-characterized perirenal aortic specimens with
immunostaining for T-cell subsets (CD3/4/8/45RA/45RO/FoxP3) and the Th1/non-Th1/Th17 ratio (CD4+T-bet+/CD4+T-bet/
CD4+/interleukin-17+ double staining). CD20 and CD138 were used to identify B cells and plasma cells, while B-cell maturation
was evaluated by AID/CD21 staining and expression of lymphoid homeostatic CXCL13. Scattered CD4 and CD8 cells with a T
memory subtype were found in normal aorta and early, nonprogressive lesions. The total number of T cells increases in progressive
atherosclerotic lesions (1:5 CD4/CD8 T-cell ratio). A further increase in medial and adventitial T cells is found upon progression
to vulnerable lesions.This critical stage is further hallmarked by de novo formation of adventitial lymphoidlike structures containing
B cells and plasma cells, a process accompanied by transient expression of CXCL13. A dramatic reduction of T-cell subsets,
disappearance of lymphoid structures, and loss of CXCL13 expression characterize postruptured lesions. FoxP3 and Th17 T cells
were minimally present throughout the atherosclerotic process.
Conclusions-—Transient CXCL13 expression, restricted presence of B cells in human atherosclerosis, along with formation of
nonfunctional extranodal lymphoid structures in the phase preceding plaque rupture, indicates a “critical” change in the
inflammatory footprint before and during plaque destabilization. ( J Am Heart Assoc. 2015;4:e001403 doi: 10.1161/
JAHA.114.001403)
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A therosclerosis is a highly dynamic
1,2 metabolic disease
with a strong inflammatory component.3–5 Compelling
evidence, largely based on data derived from murine models
of atherosclerotic disease, implies extensive involvement of
the adaptive immune response in the initiation, progression,
and complications of atherosclerotic disease.6 As a conse-
quence, the adaptive immune response is considered a
potential target for medical interventions.
An open question is how these observations translate to
the human situation. There are fundamental immunological
and inflammatory differences between mice and humans.7–9
Moreover, murine models of accelerated atherosclerotic
disease require an immunologic background with exaggerated
Th1-cell responsiveness in order for atherosclerosis to
develop.8,9 Hence, observations from mouse models may be
skewed toward Th1 response. Extrapolation of the murine
data is further complicated by absence of vulnerable lesion
formation in the current models of atherosclerotic disease. As
a result, data on a possible involvement of the adaptive
immune response in the advanced stages of atherosclerotic
disease are missing.
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Table 1. Demographic Data of the 114 Studied Aortic Samples
Male Female
N 64 50
Mean age, y (SD) 49.4 (14.3) 43.8 (17.3)
Mean length, cm (SD) 179.9 (11.9) 166.6 (12.1)
Mean weight, kg (SD) 80.1 (16.3) 64.9 (15.3)
Mean BMI, kg/m2 (SD) 24.8 (3.1) 22.9 (4.4)
Number of patients with known history of nicotine abuse 21 (36.8%) 17 (39.5%)
Number of patients with known history of hypertension* 13 (22.8%) 10 (23.3%)
Number of patients with known diabetes 0 (0.0%) 1 (2.3%)
Cause of death
Severe head trauma 11 (17.1%) 7 (14.0%)
Cerebral vascular accident 8 (12.5%) 10 (20.0%)
Subarachnoid bleeding 15 (23.4%) 14 (28.0%)
Cardiac arrest 7 (10.9%) 0 (0.0%)
Trauma 1 (1.5%) 1 (2.0%)
Other 6 (9.3%) 3 (6.0%)
Unknown 16 (25.0%) 15 (30%)
Medication
Antihypertensives 11 (19.3%) 6 (14.0%)
Statins 1 (1.7%) 1 (2.3%)
Anticoagulants 1 (1.7%) 2 (4.7%)
Other 5 (8.8%) 8 (18.6%)
None 31 (54.4%) 22 (51.2%)
Unknown 11 (19.3%) 9 (20.9%)
*Known antihypertensive medication or systolic blood pressure >140 mm Hg and diastolic >90 mm Hg in the period preceding death. BMI indicates body mass index.
Table 2. Antibodies Used in the Present Study
Antibody, Clone Host Isotype; Subclass Specificity Pretreatment Dilution Reference/Source
CD3, polyclonal Rabbit Pan T cells 10x Tris/EDTA pH 9.2 1:200 DAKO
CD4, 4B12 Mouse, IgG1-j T-helper cells 10x Tris/EDTA pH 9.2 1:200 DAKO
CD8, C8/144B Mouse, IgG1-j Cytotoxic T cells 10x Tris/EDTA pH 9.2 1:200 DAKO
CD45RA, HI100 Mouse, IgG2b-j Na€ıve T cells Citrate pH 6.0 1:2000 BioLegend
CD45RO, UCHL1 Mouse, IgG2a-j Memory T cells Citrate pH 6.0 1:1000 BioLegend
CD20, L26 Mouse Pan B cells Citrate pH 6.0 1:1000 DAKO
CD21, IF8(4) Mouse, IgG1-j Follicular dendritic Cells, mature B cells Citrate pH 6.0 1:400 DAKO
CD138, MI15 Mouse Plasma cells 10x Tris/EDTA pH 9.2 1:1000 DAKO
CCR7, ab191575 Rabbit, polyclonal Activated T-lymphocytes Citrate pH 9.2 1:200 Abcam
Tbet, polyclonal Rabbit, sc-21003 T-helper1 cells 10x Tris/EDTA pH 9.2 1:800 Santa Cruz
IL-17, polyclonal Goat Th-17 cells – pH 9.0 1:50 R&D
FoxP3, clone 236A/E7 Mouse Regulatory T cells – pH 9.0 1:50 Abcam
CXCL13, cat no AF801 Goat Lymphorganogenic chemokine Citrate pH 6.0 1:100 R&D
Anti-AID, EK2 5G9 Rat Activation-induced cytidine deaminase Citrate pH 6.0 1:16.000 Cell Signalling
AID indicates activation-induced cytidine deaminase; Ig, immunoglobulin; IL, interleukin.
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Available human data, on the other hand, largely rely on
surgical specimens. Yet, it is important to note that this
material generally represents the final stages of the disease
process.10,11 As such, data from these human studies are not
representative for the earlier and intermediate phases of
atherosclerotic disease; hence, knowledge of the nature of
the adaptive immune response in the human atherosclerotic
process is limited.
Given the above considerations, we regarded an evaluation
of the adaptive immune response within the process of
atherosclerotic lesion formation, progression, and stabiliza-
tion to be relevant. To that end, we performed comprehensive
and systematic histological assessment of cellular aspects of
the adaptive immune response in tissue samples from a
biobank of arterial tissue that covers the full spectrum of
human atherosclerotic disease. Results from this explorative
study confirm an extensive and dynamic presence of cellular
components of the adaptive immunity in the human athero-
sclerotic process, and reveal profound changes in the
inflammatory footprint immediately prior to and during the
process of plaque destabilization.
Materials and Methods
Patients and Tissue Sampling
Tissue sections were selected from a tissue bank of aortic
wall patches that were obtained during liver, kidney, and
Figure 1. Example of the regions of interest as used for the
assessment of immunolocalization of T cells (and T-cell subset), B
cells, and plasma cells in a healed rupture. The regions of interest
are drawn in the fibrous cap, in 1 of the shoulders and 3 times in
the media in this particular example. For every lesion (normal or
ruptured), a total of 9 images were made (3 in the intima, 3 in the
media, and 3 in the adventitia) and the immunostaining was





Figure 2. High-resolution examples of the immunohistochemi-
cal staining for CD3, CD4, and CD8 cells. The high-resolution
images are examples of the quality of the immunohistochemical
staining for CD3, CD4, and CD8. All images were taken at a
9400 magnification at the medial adventitial border. Within all
the images, one can see the clear positively stained T cells
mainly located near the vasa vasorum. All sections were
developed with Diaminobenzidine (DAB) and counterstained with
Mayer’s hematoxylin.
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pancreas transplantation with grafts derived from cadaveric
donors. Details of this bank have been described previously
by van Dijk et al12 All patches were from grafts that were
eligible for transplantation (ie, all donors met the criteria set
by The Eurotransplant Foundation). Due to national regula-
tions, only transplantation-relevant data for donation are
available, as such background information on the specimens
is limited. Sample collection and handling was performed in
accordance with the guidelines of the Medical and Ethical
Committee in Leiden, Netherlands and the code of conduct of
the Dutch Federation of Biomedical Scientific Societies
(http://www.federa.org/?s=1&m=82&p=0&v=4#827).
Each tissue block in the bank was Movat and H&E stained
and classified according to the modified American Heart
Association (AHA) classification as proposed by Virmani et al
by 2 independent observers with no knowledge of the
characteristics of the aortic patch.12,13 The tissue block
showing the most advanced plaque was used for further
studies. In order to obtain balanced and representative study
groups, we selected the first 100 aortic wall samples from the
tissue bank. Due to the fact that the vulnerable lesions (ie,
thin cap fibroatheroma and plaque ruptures) were under-
represented, we randomly selected several aortic wall sam-
ples classified as vulnerable lesions from the remaining 250
patches in order to obtain approximately 10 to 12 samples
from each atherosclerotic stage. A total of 114 cases were
selected for further examination. Demographic data and the
causes of death are summarized in Table 1.
Characterization of the Lesions and Histological
Definitions
Aortic samples not showing any signs of intimal thickening
and intimal inflammation where classified as normal. The
other samples were classified based on the most advanced
lesion type present in the section. Lesions were defined as
adaptive intimal thickening, intimal xanthoma, pathological
intimal thickening, early fibroatheroma, late fibroatheroma,
thin-cap fibroatheroma, acute plaque rupture, healed plaque
rupture, and fibrotic calcified plaque. Detailed descriptions
concerning a complete overview on plaque processing,
morphological analysis, and additional information concerning
the studied population are provided in van Dijk et al12
Immunohistochemistry
All specimens used for immunohistochemistry (IHC) were
washed in PBS, formalin fixed, and decalcified (Kristensens
solution), and paraffin embedded using standard procedures.
The details of the antibodies used for IHC are listed in Table 2.
Conjugated biotinylated horse anti-mouse (1:400 dilution;
Vector laboratories, Amsterdam, the Netherlands) or Envi-
Table 3. Histological Classification of Aortic Tissue According to the Modified American Heart Association Classification Proposed
by Virmani et al
Morphological Description Abbreviation
Male Female Total
N Mean Age (SD) N Mean Age (SD) N
Normal aorta N 7 23.8 (18.9) 5 10.0 (3.7) 12
Nonprogressive intimal lesions
Adaptive intimal thickening AIT 5 40.5 (10.0) 5 30.4 (9.0) 10
Intimal xanthoma IX 7 37.3 (10.0) 5 34.2 (14.8) 12
Progressive atherosclerotic lesions
Pathological intimal thickening PIT 5 46.0 (8.9) 7 55.4 (11.5) 12
Early fibroatheroma EFA 7 50.9 (5.9) 5 46.0 (3.5) 12
Late fibroatheroma LFA 5 55.0 (3.6) 7 51.1 (11.6) 12
Vulnerable atherosclerotic lesions
Thin-cap fibroatheroma TCFA 7 57.2 (5.2) 4 60.3 (5.7) 11
Plaque rupture PR 7 56.9 (2.6) 3 45.0 (13.1) 10
Stabilizing lesions
Healing rupture HR 8 58.1 (11.1) 4 57.0 (0) 12
Fibrotic calcified plaque FCP 6 62.7 (6.8) 5 53.0 (11.4) 11
64 49.4 (14.3) 50 43.8 (17.3) 114
AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; FCP, fibrotic calcified plaque; HR, healed rupture; IX, Intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT,
pathological intimal thickening; PR, plaque rupture; SD, standard deviation; TCFA, thin cap fibroatheroma.
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sion+ System–horseradish peroxidase–labeled polymer anti-
mouse/anti-rabbit (prediluted; Dako, Heverlee, Belgium) func-
tioned as secondary antibodies. Sections were developed with
Nova Red or DAB and counterstained with Mayer’s hematox-
ylin or methyl green. Positive and negative controls were
always included and performed by adding or omitting the
primary antibody on 3-aminopropyltriethoxysilane slides con-
taining human tonsils.
The Foxp3/CD3 and interleukin-17/CD3 double staining
was performed to identify regulatory T cells and Th17 cells,
respectively (Table 1). Conjugated polymer anti-mouse/anti-
rabbit (Immunologic) functioned as secondary antibodies.
After the goat-derived anti-interleukin-17 incubation, a rabbit
anti-goat secondary antibody (Southern Biotech, Birmingham,
AL) served as a bridge reagent for the next step with alkaline
phosphatase anti-rabbit polymer (Immunologic, Duiven, the
Netherlands). All immunohistochemical stainings were per-
formed as previously described.14 Despite many attempts and
various techniques, we did not succeed in using GATA-3 as
the T-helper 2 marker. We therefore had to turn to double
staining for CD4/Tbet to identify the T-helper lineage
(Lineage: Th1=CD4+/Tbet+ and non-Th1=CD4+/Tbet) having
regard to the provision that non-Th1 may also include Th0,
Th17, and Th22 populations.
Assessment of Immunolocalization of T Cells (and
T-Cell Subset), B Cells, and Plasma Cells
The tissue block showing the most advanced plaque was used
for further studies. When the aortic sample contained more
than 1 lesion, the most advanced lesion on the slide was
used. The lesion was defined as the area between the
endothelium and the first elastic lamina over a distance of
1 mm. In the presence of a necrotic core, the distance was
expanded with another 500 lm on both sides of the necrotic
core to include the adjacent shoulder region.12 The regions of
interest were the intima (and in the presence of an early or
late necrotic core, the intima was divided into a cap and both
shoulder regions), the media, and the adventitia (Figure 1).
Within the regions of interest (ie, intima, media, and
adventitia), 3 representative adjacent images were made at
a 9200 magnification. A total of 9 images per atherosclerotic
lesion were separately analyzed from the lesion. Immuno-
staining intensity was quantitatively assessed with an image-
processing program (Image J; plug-in Cellcounter). Represen-
tative examples of the immunological stainings are provided in
Figure 2.
Statistical Analysis
Data in figures are presented as meanSEM. Spearman’s
correlation was used to demonstrate the relationship
between the amount of positive cells in the intima, media,
and adventitia within 1 phase of the atherosclerotic
disease and compared with the previous and/or next
A
B
Figure 3. The CD4/CD8 and Th1/non-Th1 ratio per stage of
atherosclerosis. A, The number of CD8 cells dominate the overall
T-cell count in normal aortas and in the early stages of
atherosclerosis up until the early fibroatheroma. In late fibroath-
eroma, vulnerable atherosclerosis (ie, thin-cap fibroatheroma and
plaque ruptures), and postruptured plaques, the total number of
CD4 and CD8 cells are practically in balance. B, Non-Th1 cells
dominate the T-helper lineage not only in normal aortas, but also
during the entire development of atherosclerotic lesions. Within
thin-cap fibroatheroma, the non-Th1 cells dominate the Th1 cells
with a factor 5 and as the lesion stabilizes, the Th1/non-Th1 cell
ratio returns to 0.4–0.5 as seen in normal aortas. The solid bars
represent the mean number of CD4 (A) or Th1 (B) cells per stage
of atherosclerosis divided by the mean number of CD8 (A) or non-
Th1 (B) cells per stage of atherosclerosis. AIT indicates adaptive
intimal thickening; EFA, early fibroatheroma; FCP, fibrotic calcified
plaque; HR, healed plaque rupture; IX, intimal xanthoma; LFA, late
fibroatheroma; N, normal; PIT, pathological intimal thickening; PR,
acute plaque rupture; TCFA, thin-cap fibroatheroma.
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phase in atherosclerosis (SPSS 20.0; Chicago, IL). The
study population consisted of 114 individuals. However,
during the staining process some tissue samples were lost.
Therefore, the total number of samples for each staining
may be less than 114. The Wilcoxon–Mann–Whitney test






Figure 4. Number of regulatory T cells within the various layers of the aortic wall per stage of atherosclerosis. Only 1 aortic sample with
an intimal xanthoma stained positive for FoxP3+ T cells (4 scattered cells). Within the aortic samples classified as a thin-cap fibroatheroma,
2 lesions showed 12 and 24 FoxP3+ T cells in the intima with 20 and 12 FoxP3+ T cells, respectively, in the adjacent adventitia. A few
scattered FoxP3+ T cells were seen in the intima of 2 healed ruptured plaques. The additional figures show a hematoxylin and eosin (H&E)–
stained adventitial follicle in a thin-cap fibroatheroma with the consecutive sections stained for regulatory T cells (CD3+/FoxP3+) and Th17
cells (CD3+/interleukin [IL]17+). There are a limited number of regulatory T cells (black arrows) in the vulnerable phase and Th17 cells were
not identified. A few scattered CD3/IL17+ cells (white arrow) were seen in the adventitia that, as previous studies showed, can be
addressed to macrophages.15 A human tonsil (not associated with the aortic biobank) functioned as a positive control for the CD3/IL17
staining and showed numerous Th17 cells. Ferangi blue was used to develop CD3 and alkaline phosphatase for FoxP3 and IL17. The solid
bars represent the number of FoxP3+ T cells within the various layers of the aorta per stage of atherosclerosis. Total number of cases: 97 (N
[9], AIT [9], IX [11], PIT [11], EFA [10], LFA [9], TCFA [9], PR [10], HR [8] and FCP [11]). For a detailed description concerning the
classification, see the Materials and Methods section. All images were taken at a 9400 magnification. AIT indicates adaptive intimal
thickening; EFA, early fibroatheroma; FCP, fibrotic calcified plaque; HR, healed plaque rupture; IX, intimal xanthoma; LFA, late
fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, acute plaque rupture; TCFA, thin-cap fibroatheroma.
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the mean total number of cells within each atherosclerotic
phase, and the Kruskal–Wallis test was used to control for




Characteristics of the studied population are provided
in Table 1. The male/female ratio was evenly distributed
(57% male), as was the mean age for each sex (49 years).
There was a strong correlation between donor age and
atherosclerosis progression12 (Table 3). The mean donor
age for the aortic wall samples classified as normal was 23
years, whereas the mean age for aortas with fibrotic
calcified plaques, representing the final stage of the
disease, was 62 years. Nearly 40% of patients had a
known history of smoking, and 2 patients received statin
therapy. Twenty-three patients had a known history of
hypertension; 17 of these patients received antihyperten-
sive medication.
A B
Figure 5. Number of CD3+, CD4+, and CD8+ T cells within the various layers of the aortic wall. A, Intimal CD3+ T cells are present in all
stages of atherosclerosis. There is a significant influx of CD3+ T cells in intimal xanthomas and pathological intimal thickening when
compared to normal aortic wall samples (*P<0.009). The number stabilizes as the lesion becomes vulnerable (viz, TCFA and PR). A
significant decrease (†P<0.014) is seen in the stabilizing lesions (viz. HR and FCP) compared to vulnerable lesions (viz, TCFA and PR). The
media remains clear of CD3+ T cells until pathological intimal thickening and shows a remarkable increase in CD3+ expressing T cells
(‡P<0.0001) in vulnerable lesions. There are an increasing number of CD3+ T cells in the adventitia with advancing atherosclerosis.
Stabilized plaques are hallmarked by a significant decrease in adventitial CD3+ T cells (§P<0.0001) when compared to the vulnerable
lesions. B, The total number of CD3+ T cells in all vascular layers increases with advancing atherosclerosis. Progressive atherosclerotic
lesions (viz, PIT, EFA, and LFA) show significantly more CD3+ T cells compared to nonprogressive lesions (AIT and IX; *P<0.0001). A
further increase is seen in vulnerable lesions (†P<0.0001), whereas lesion stabilization is hallmarked by a dramatic decrease
(‡P<0.0001). Total number of cases in (A) and (B): 95 (N [9], AIT [9], IX [11], PIT [12], EFA [9], LFA [8], TCFA [9], PR [10], HR [7], and FCP
[11]). C, The intima remains practically devoid of CD4+ T cells up until late fibroatheroma. There is a significant increase of T-helper cells
in vulnerable lesions compared to PIT, EFA, and LFA followed by a significant decrease in stabilizing lesions (*P<0.008; †P<0.004).
Similar patterns are seen within the media and adventitia (‡P<0.0001; §P<0.003; ;P<0.002װ and #P<0.008). D, T-helper cells
significantly increase in progressive and vulnerable lesions in comparison to PIT, EFA, and LFA followed by a decrease in stabilized
lesions (*P<0.021; †P<0.0001; and ‡P<0.001). Total number of cases in (C) and (D): 91 (N [8], AIT [9], IX [11], PIT [11], EFA [8], LFA [10],
TCFA [9], PR [9], HR [7] and FCP [9]). E, Cytotoxic T cells are more abundantly present in the intima in the progressive stages of
atherosclerosis (*P<0.001) when compared to normal, AIT and IX. The media and adventitia show an increasing number of cytotoxic T
cells within progressive atherosclerotic lesions (PIT, EFA, and LFA) compared to the prior phases followed by a significant rise within the
vulnerable plaques and a significant decrease as the lesions stabilize (†P<0.0001; ‡P<0.0001; §P<0.0001; and .(P<0.0001װ F, The total
number of cytotoxic T cells follows a similar pattern to that of the T-helper lineage in (B): a significant increase within progressive and
vulnerable lesions followed by a decrease in stabilized lesions (*P<0.002; †P<0.0001, and ‡P<0.0001). Total number of cases in (E) and
(F): 96 (N [9], AIT [9], IX [10], PIT [12], EFA [10], LFA [10], TCFA [9], PR [10], HR [8] and FCP [9]). The vertical axis of (A), (C), and (E) is
presented as a log-scale. Each solid bar in (A), (C), and (E) represents the number of positively stained T cells within the intima, media,
and adventitia of 1 aortic plaque. The solid bars in (B), (D), and (F) represent the mean total number of cells within the entire aortic wall
per stage of atherosclerosis SEM. AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; HR, healed rupture; FCP, fibrotic
calcified plaque; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, plaque rupture; TCFA,
thin-cap fibroatheroma. For a detailed description concerning the classification, see the Materials and Methods section.
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Normal Aorta and Nonprogressive
Atherosclerotic Lesions
The intima and media layers of the normal (nonatheroscle-
rotic) aortic wall are devoid of CD3+ T cells (Figures 3 through
10). Scattered T cells found at the medial–adventitial border
are mainly CD45RO+ (memory) T cells. The CD4+ (Thelper) to
CD8+ (cytotoxic) T-cell ratio is approximately 1:2 (Figure 3A).
Th1 cells) and non-Th1 cells were also expressed in a 1:2 ratio
(Figure 3B).
Na€ıve T cells (CD45RA+), regulatory T cells (CD3+/FoxP3+),
Th17 cells (CD3+/IL17A+), B cells (CD20+), and plasma cells
(CD138+) are all absent in aortas classified as normal.
Isolated T cells in the thickened intima, and progressive
numbers of T cells in the medial/adventitial border charac-
terize so-called nonprogressive lesions (ie, adaptive intimal
thickening and intimal xanthomas). Memory T cells remain the
dominant phenotype, and the subset ratios remains
unchanged (CD4+/8+; Th1/Th2). Regulatory T cells, Th17
cells, na€ıve T cells, B cells, and plasma cells are absent in
these early lesions (Figure 4).
Progressive Atherosclerotic Lesions
A significant increase is seen in intimal CD3+ T cells
(P<0.0001) in progressive lesions (early fibroatheroma and
late fibroatheroma) with beginning infiltration of the medial
wall as well. The predominance of cytotoxic T cells persists
(CD4+: CD8+ T-cell ratio 1:5) in the early fibroatheroma,
and T-helper cells are dominated by the Th1 lineage at
a 1:3 ratio. Transition from an early to late fibroathero-
ma stage is accompanied by the accumulation of T cells
in the intima shoulder regions of the lesion, and the
CD4+/CD8+ T-cell ratio shifts from 1:5 in early fibroat-
heroma to 1.5:1 in late fibroatheroma (Figures 3
through 9).
Memory T cells remain the dominant phenotype in
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to appear within the medial–adventitial border in lesions
classified as early fibroatheroma. A further increase in na€ıve T
cells and T memory cells is seen in late fibroatheroma with a
notable accumulation of T cells alongside infiltrating vasa
vasorum in the outer layers of the media underlying the
necrotic core. In general, B cells and plasma cells are absent,
although present in a minority of individuals (Figure 9).
Regulatory T cells and Th17 cells are not identified in the
progressive lesions.
The Vulnerable Lesions
Thin-cap fibroatheromas and ruptures are hallmarked by a
peak in T-cell infiltration in the adventitia underneath the
culprit lesion (Figures 3 through 9). The thin cap remains
devoid of T cells, and the number of T-helper cells
decreases, resulting in an approximate 1:1 CD4/CD8 cell
ratio. Non-Th1 cells remain the dominant T-helper lineage in
the vulnerable phase, due to doubling of the number of non-
Th1 cells (Figure 6). Dispersed memory T cells and na€ıve T
cells are abundantly present in the media and adventitia
near the vasa vasorum. Absence of CD45RO/CCR7 double-
positive cells indicates that all CD45RO+ T cells within the
lesion and infiltrates are effector memory T cell and the only
few central memory T cells are identified in the aortic wall
located within the vasa vasorum of the adventitia (Fig-
ure 10).
A unique finding in the vulnerable lesions is the appear-
ance of B cells and occasional plasma cells in tertiary
folliclelike structures. Staining for CXCL13, a homeostatic,
lymphorganogenic chemokine that is critical for organization
of folliclelike structures, shows CXCL13 expression exclu-
sively in vulnerable lesions (viz, no CXCL13 staining was
found in the other stages of the disease) and reveals a
particular staining pattern of a dendritic network with
extension from the follicles (Figure 9). Additional staining
A
Figure 6. Number of Thelper1 and non-Thelper1 cells within the various layers of the aortic wall. A, There is a gradual increase in Thelper1
cells in the intima and adventitia with advancing atherosclerotic lesions. An increase is seen in the amount of Thelper1 cells within ruptured
plaques; note the fact that these cells are mainly located in the adventitia. Total number of cases in (A): 97 (N [9], AIT [9], IX [11], PIT [11],
EFA [12], LFA [8], TCFA [12], PR [8], HR [9] and FCP [8]). B, There are far more non-Thelper1 cells within the aortic wall compared to the
number of Thelper1 cells. However, the same gradual increase in number is seen as the atherosclerotic lesions progress toward the
vulnerable thin-cap fibroatheroma. Again, an increase is seen within ruptured plaques. Total number of cases in (B): 98 (N [8], AIT [10], IX [11],
PIT [10], EFA [12], LFA [9], TCFA [12], PR [8], HR [10] and FCP [8]). C, Illustrative images of the adventitia adjacent to the intimal plaque in the
various stages of the atherosclerotic process with CD4/Tbet double-staining corresponding with the presented graphs (A and B). Thelper1
cells are identified by staining positive for CD4 (brown; diaminobenzidine chromogen) and Tbet (methylgreen). Non-Thelper1 cells are CD4
positive and Tbet negative. Note that there are numerous cells that only stain Tbet positive. The vertical axis of the figures with the intima,
media, and adventitia separated is presented as a log-scale and the solid bars represent the number of Thelper1 or non-Thelper1 cells within
the various layers of 1 aortic plaque. The solid bars in the adjacent figures represent the mean total number of Th1 cells or non-Th1 cells
within the entire aortic wall SEM. AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; HR, healed rupture; FCP, fibrotic
calcified plaque; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, plaque rupture; TCFA, thin-
cap fibroatheroma. For a detailed description concerning the classification, see the Materials and Methods section. All images were taken at
9400 magnification.
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for mature B cells (CD2) and activation-induced cytidine
deaminase was mainly negative, indicating the lack of B-cell
maturation. Scattered FoxP3+ T cells are found within the
intima and underlying adventitia in 2 of 9 aortic sections of
thin-cap fibroatheroma (Figure 4). On the other hand, Th17
cells are absent in vulnerable lesions.
Advena of TCFAAdvena of PIT
Advena of EFA Advena of PR
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Stabilized Lesions
Healing plaque ruptures exhibit a dramatic decrease in T
cells (P<0.001), na€ıve T cells, and disappearance of B cells
and plasma cells (Figures 2 through 9). The decline in T
cells is greater for the CD4+ cells than for the CD8+ cells
for all vascular layers. Within the thin-cap fibroatheroma,
non-Th1 cells dominate over Th1 with a 5-fold-increase, and
in stable lesions the Th1/non-Th1 cell ratio returns to 1:2
as seen in normal aortas (Figure 3B). The decline in memory
T cells predominantly reflects a reduction localized to the





Figure 7. Number of memory T cells within the various layers of the aortic wall. A, Progressive atherosclerotic lesions and vulnerable plaques
represent a high amount of CD45RO+ T cells in the intima (*P<0.011). Only fibrotic calcified lesions show a significant decrease compared to
vulnerable lesions (†P<0.001). In comparison with normal, AIT and IX (viz. Nonprogressive intimal lesions) the media and adventitia show an
increasing number of memory T cells within progressive atherosclerotic lesions followed by a significant rise within the vulnerable plaques and a
significant decrease as the lesions stabilize (†P<0.0001; ‡P<0.0001; §P<0.0001; and .(P<0.0001װ B, Memory T cells significantly increase in
number within progressive and vulnerable lesions followed by a decrease in stabilized lesions (*P<0.0001; †P<0.0001 and ‡P<0.0001). C and D,
Illustrative images of the CD45RO staining of, respectively, the adventitia of a LFA and the adventitia of a TCFA corresponding with the
presented graphs. All sections were developed with DAB and counterstained with Mayer’s hematoxylin. The vertical axis of (A) is presented as a
log-scale. The solid bars in (A) represent the number of CD45RO+ T cells within the various layers of 1 aortic plaque. The solid bars in (B)
represent the mean number of CD45RO+ T cells within the entire aortic wall of 1 aortic plaque SEM. Total number of cases in (A) and (B): 95 (N
[9], AIT [9], IX [12], PIT [11], EFA [9], LFA [9], TCFA [9], PR [10], HR [7] and FCP [10]). AIT indicates adaptive intimal thickening; EFA, early
fibroatheroma; HR, healed rupture; FCP, fibrotic calcified plaque; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological
intimal thickening; PR, plaque rupture; TCFA, thin-cap fibroatheroma. For a detailed description concerning the classification, see the Materials
and Methods section. All images were taken at 9400 magnification.
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the media and adventitia remains stable. Native T-cell
numbers are highly variable. The folliclelike structures vanish
and CXCL13 disappeared from the arterial wall. No regula-
tory T cells or Th17 cells are detected in the stabilized
lesions.
Discussion
A wealth of preclinical evidence supports a critical role of
the adaptive immunity in the initiation and progression of
atherosclerosis.17,18 This study, based on histological
observations in human aorta sections, confirms extensive
and progressive involvement of cellular components of the
adaptive immune response in atherosclerosis.19 Findings
point to profound changes in the nature of the response in
the lead-up to plaque destabilization and show extinguishing
of inflammatory processes upon plaque stabilization. This
study reveals fundamental differences between the human
atherosclerotic disease and mouse models of the disease,
particularly with respect to a very limited presence of
regulatory T cells, absence of Th17 cells throughout the
atherosclerotic process, and lack of B cells in the early-,
intermediate-, and final stages of the process.
Insight into the atherosclerotic process greatly depends on
observations from murine models of the disease.20 Indeed,
genetically modified mouse models have been critical for
A B
C D E
Figure 8. Number of na€ıve T cells within the various layers of the aortic wall. A, Limited numbers of CD45RA+ T cells are detected in the intima
of vulnerable lesions. However, the media and adventitia contain a significant increase in na€ıve T cells within the vulnerable lesions compared to
the progressive lesions (EFA and LFA) followed by a decrease in stabilized lesions (*P<0.001; †P<0.006; ‡P<0.0001; and §P<0.0001). B, Na€ıve T
cells increase significantly in number in vulnerable plaques (*P<0.0001) and decrease dramatically in number when the lesions stabilize
(†P<0.0001). The vertical axis of (A) is presented as a log-scale. The solid bars in (A) represent the number of CD45RA+ T cells within the various
layers of 1 aortic plaque. Notice the significant increase of adventitial na€ıve T cells in the vulnerable lesions (D and E) compared to the
progressive lesions (C) and the na€ıve T cells alongside the vasa vasorum (black arrows). All sections were developed with DAB and
counterstained with Mayer’s hematoxylin. The solid bars in (B) represent the mean number of CD45RA+ T cells within the entire aortic wall of 1
aortic plaque SEM. Total number of cases in (A) and (B): 97 (N [9], AIT [9], IX [11], PIT [11], EFA [10], LFA [9], TCFA [9], PR [10], HR [8], and FCP
[11]). AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; HR, healed rupture; FCP, fibrotic calcified plaque; IX, intimal xanthoma;
LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, plaque rupture; TCFA, thin-cap fibroatheroma. For a detailed
description concerning the classification, see the Materials and Methods section. All images were taken at 9400 magnification.
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understanding the atherosclerotic process. Yet, by virtue of
the metabolic adaptations in the lipoprotein metabolism,
necessary to induce atherosclerotic lesion formation, the
process in these animals is essentially lipid driven (a situation
that may not fully mimic the human situation).21,22 Translation
of rodent findings is further obscured by critical dependence
on genetic backgrounds with Th1-dominated immune
responses in order for atherosclerosis to develop; by the
fundamental and intrinsic differences in inflammatory and
immune responses between mice and humans; and by failure
of the experimental lesions to progress to culprit lesions
(vulnerable plaque) formation.7,23,24 Consequently, informa-
tion provided by these models may be biased, and is
incomplete at least with respect to vulnerable lesions. As a
result, the preclinical observations may not directly translate
to the human situation.8,9
Data on human atherosclerosis are also limited, a situation
largely reflecting the fact that most observations are made on
material obtained during surgical procedures (eg, endarterec-
tomy). This material typically represents the final stage(s) of
the disease and, in the case of an endarterectomy material,
will not provide information on the outer media and the
adventitia, both major interphases in vessel wall inflamma-











Figure 9. Number of CD20+ B cells and CD138+ plasma cells in the various layers of the aortic wall. The intima and media of the aortic wall
remain largely deprived of CD20+ B cells and CD138+ plasma cells (A and B, respectively), although incidental B cells are found in the adventitia.
There is a significant increase in the amount of B cells and plasma cells in the adventitia in close proximity to the intimal plaque in the vulnerable
lesions compared to the prior phase (*P<0.0001 and *P<0.003). Total number of cases: 97 (N [9], AIT [9], IX [11], PIT [11], EFA [10], LFA [9],
TCFA [9], PR [10], HR [8], and FCP [11]). C, An adventitial follicle in a thin-cap fibroatheroma consecutively stained for CD20, CD21, and
CXCL13. Notice the abundance of (CD21-negative) B cells clustered around the CXCL13 positive radiating pattern of tubelike structures. Anti–
activation-induced cytidine deaminase (AID) stained negative within the adventitial infiltrates. Due to the disturbing amount of background
staining, a high-resolution image of a positive control for the anti––AID staining in a human tonsil is provided to illustrate the mature B cell. All
images were taken at 9400 magnification. All sections were developed with Diaminobenzidine (DAB) and counterstained with Mayer’s
hematoxylin. The vertical axis is presented as a log-scale. The solid bars represent the number of CD20+ B cells or CD138+ plasma cells within
the various layers of 1 aortic plaque. AIT indicates adaptive intimal thickening; EFA, early fibroatheroma; HR, healed rupture; FCP, fibrotic
calcified plaque; IX, intimal xanthoma; LFA, late fibroatheroma; N, normal; PIT, pathological intimal thickening; PR, plaque rupture; TCFA, thin-cap
fibroatheroma. For a detailed description concerning the classification, see the Materials and Methods section.
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samples from organ grafts designated for transplantation.
Material from this bank almost covers the full life span (5 to
80 years) and shows a nearly equal sex distribution. The
relatively healthy premortal status of the donors is reflected
by minimal use of statins and antihypertensive drugs.
Classification was done for all individual tissue sections in
the bank (viz, each individual tissue block was Movat and
hematoxylin stained, and histologically staged using an
established adapted version of the AHA classification sys-
tem).12,13 Modifications in the adapted classification system
highlight specific critical morphological events in the final
stages of the disease process. This allows for a more precise
interpretation of processes occurring during plaque destabi-
lization and subsequent healing. An earlier systematic eval-
uation of material in the biobank showed that the bank covers
the full spectrum of atherosclerotic disease.12 Exact morpho-
logic descriptions and examples of the different lesions have
been published and discussed previously.12
Immunohistochemical staining for CD3, CD4, and CD8
shows progressive T-cell accumulation during the athero-
sclerotic process. The earlier phases are dominated by
diffuse cytotoxic T-cell infiltration, but progressive quantities
of T-helper cells are found during progression of the
disease, resulting in an increase in the CD4+/CD8+ T-cell
ratio during disease progression. These observations are in
line with an earlier report on renal artery atherosclerosis,
and with observations from other progressive inflammatory
disorders.25,26 Due to inherent limitations of paraffin-
embedded tissue, we were unable to test whether these
shifts reflect an (auto)immune phenomenon, as has been
proposed in the context of advanced atherosclerotic
disease.27,28
CD4/T-Bet double staining was used to identify Th1 cells.
T-bet is the lineage-defining transcription factor for Th1
cells.29 In the absence of Th17 and with minimal regulatory T
cells throughout the atherosclerotic spectrum, we defined the
CD4+/T-bet-negative cells as non-Th1 cells. Quantification of
the Th1/non-Th1 ratio on the basis of the CD4/T-Bet double
staining did not confirm Th1 dominance in the human
atherosclerotic process. This may indicate that the presumed
Th1 dominance in atherosclerosis reflects an artificial
phenomenon related to the requirement of Th1-dominated
backgrounds in mouse models in order for atherosclerosis to
develop. Yet, alternative explanations are that identification
based on T-Bet positivity underestimates the number of Th1
cells or, vice versa, that identification based on cytokine
profiles overestimates the number of Th1 cells.30
Findings for the CD45RO (T-memory cells) and CD45RA
(na€ıve T cells) largely follow observations for other solid
organs (predominance of T-memory cells) and extend those











Figure 10. Thin-cap fibroatheroma stained for CD45R0/CCR7.16
Immunohistochemical double staining for CCR7/CD45R0 was done
to differentiate between effector memory T cells (CCR7) and
central memory T cells (CCR7+). A, The adventitia of the aortic wall
containing a thin-cap fibroatheroma consists of numerous T cells in
follicle-like structures. All the CD45R0+ T cells (chromogen Ferangi
blue) within the lesion and infiltrates are effector memory T cell
(CCR7; otherwise warp red [klinipath, Duiven, Netherlands]).
Only a few cells stain positive for CCR7 but negative for CD45R0. B,
The only few central memory T cells (CD45R0+/CCR7+)
identified in the aortic wall are located within the vasa
vasorum of the adventitia. The image was taken at 9400
magnification.
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increasing T-cell infiltration during disease progression, with a
clear maximum during plaque destabilization followed by a
rapid decline during plaque stabilization (plaque healing).31 A
remarkable and novel observation is the change in the
inflammatory footprint that accompanies plaque destabiliza-
tion, and that fully resolves during plaque stabilization. This
change appears to precede plaque destabilization, and is
confined to the area adjacent to the culprit lesion. On the
cellular level, this change is characterized by a sharp increase
in the number of T-helper cells, emergence of na€ıve T-cells,
and the appearance of B cells and occasional plasma cells in
tertiary folliclelike structures. B cells in the follicles are largely
activation-induced cytidine deaminase and CD21 negative,
indicating gross absence of B-cell maturation.32,33 These
observations suggest that signals promoting B-cell homing
and follicle assembly accompany (and may even precede)
plaque destabilization, but that essential signals critical for
maturation of B cells are missing.
The chemokine CXCL13 is a pivotal homeostatic signal for
follicle formation.34,35 As for the appearance of folliclelike
structures, we performed immunostaining for CXCL-13 and
observed CXCL-13 expression exclusively in association with
the folliclelike structures in the vulnerable lesions (viz, CXCL-13
was not detected in the other stages of the disease). CXCL13
distribution shows a remarkable radiating pattern of tubelike
structures that may reflect expression in dendritic cells.36
In light of the remarkable association between CXCL13
and plaque instability, we tested an association between
plasma CXCL13 levels and acute cardiovascular events (acute
myocardial infarction) in plasma samples of the Mission
study.36 CXCL13 was largely undetectable, and no association
was found between CXCL-13 and cardiovascular events
(results not shown). Absence of such an observation may
reflect the highly localized character of CXCL13 expression in
the vulnerable lesion.
B cells are considered critical players in the atherosclerotic
process, albeit their role (protective, detrimental) is still under
debate.37,38 Our findings of a very restricted presence of B
cells in human atherosclerosis follow observations from
Frostegard et al39 Hence, these findings and gross absence
of signs of B-cell maturation in the infiltrating B cells exclude
an autocrine or paracrine role of B cells in the human
atherosclerotic process. Yet, humoral factors released by B
cells in paravascular lymph nodes or more distant locations
may well be involved in the disease process.
Regulatory T cells were incidentally found in a subset of the
vulnerable lesions, whereas Th17 cells were fully absent in the
aortic sections. This latter observation follows results of a
comprehensive analysis of cytokines in atherosclerotic wall
samples that failed to detect interleukin-17 in all samples
tested (detection threshold of the assay <1 pg/L).40 Although
these observations do not exclude a distant role for these cell
populations, they seem to contradict observations from
murine models implying these cells as local key-players in
the atherosclerotic process.
Limitations
This study was performed on aortic sections of deceased
individuals, as such the continuous data in this study are
composed of incidental findings from a large series of patients
and therefore may not necessarily reflect longitudinal data.
Another limitation of the study is the fact the all findings are
based on IHC using paraffin-embedded tissue sections.
Although IHC has the advantage of showing the spatial
relationships, multiple stainings are elaborative, and only
allow for very limited marker sets. Consequently, findings in
this study should be considered at a global level. That is, the
apparent mismatch between the total number of CD3 counts
and the sum of CD4 and CD8 may reflect abundance of other
CD3-expressing populations such as NK and NK-T cells but
also reflect technical limitations of IHC with different epitope
availabilities and antibody efficacies. Yet, it is likely that the
latter phenomena would equally apply to all tissue sections,
and it is thus unlikely that this would influence the conclu-
sions of the study.
In conclusion, this study shows clear changes in the
cellular components of the adaptive immune system in
anticipation of and during plaque destabilization. Observations
suggest that changes in the inflammatory footprint precede
and accompany plaque instability. It is tempting to speculate
that delineation of this chain of events may provide clues for
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